BRA
EXEL icon

Bender Robert & Associates’s Exelixis EXEL Stock Holding History

Bender Robert & Associates’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-58,469
Closed -$1.24M – 47
2021
Q3 		$1.24M Sell
58,469
-14,746
-20% -$274K 0.35% 30
2021
Q2 		$1.33M Sell
73,215
-9,515
-12% -$222K 0.38% 29
2021
Q1 		$1.87M Sell
82,730
-2,815
-3% -$63.6K 0.6% 28
2020
Q4 		$1.72M Sell
85,545
-2,045
-2% -$42.8K 0.55% 28
2020
Q3 		$2.14M Sell
87,590
-2,580
-3% -$60.2K 0.77% 26
2020
Q2 		$2.14M Buy
90,170
+2,410
+3% +$55.9K 0.85% 25
2020
Q1 		$1.51M Buy
87,760
+200
+0.2% +$3.66K 0.8% 25
2019
Q4 		$1.54M Sell
87,560
-6,205
-7% -$105K 0.7% 26
2019
Q3 		$1.66M Sell
93,765
-2,045
-2% -$41.4K 0.83% 25
2019
Q2 		$1.99M Sell
95,810
-3,515
-4% -$73.7K 0.95% 25
2019
Q1 		$2.36M Buy
99,325
+4,380
+5% +$99.9K 1.16% 25
2018
Q4 		$1.87M Sell
94,945
-22,345
-19% -$398K 1.08% 25
2018
Q3 		$2.08M Buy
117,290
+170
+0.1% +$3.31K 0.95% 26
2018
Q2 		$2.52M Buy
117,120
+25,955
+28% +$537K 1.32% 25
2018
Q1 		$2.02M Buy
+91,165
New +$2.52M 1.12% 25

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bender Robert & Associates's EXEL Position: Q4 2021 in Review

Bender Robert & Associates sold out of Exelixis (EXEL) in Q4 2021, closing a stake of 58,469 shares — an estimated $1.24M sold.

Bender Robert & Associates first reported a position in EXEL in Q1 2018 and held it in 15 quarters. The position peaked at $2.52M in Q2 2018. 328 funds tracked by Wall St. Rank hold EXEL as of Q4 2021.

  • Bender Robert & Associates reported no remaining Exelixis position as of Q4 2021 after selling out during the quarter.
  • Bender Robert & Associates sold 58,469 Exelixis shares in Q4 2021, an estimated $1.24M.
  • Bender Robert & Associates first reported a position in Exelixis in Q1 2018 and held it in 15 quarters.
  • Bender Robert & Associates's Exelixis position peaked at $2.52M in Q2 2018.
  • 328 funds tracked by Wall St. Rank held Exelixis as of Q4 2021.

Based on Bender Robert & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.